258 related articles for article (PubMed ID: 16417964)
1. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study.
Giannantoni A; Costantini E; Di Stasi SM; Tascini MC; Bini V; Porena M
Eur Urol; 2006 Apr; 49(4):704-9. PubMed ID: 16417964
[TBL] [Abstract][Full Text] [Related]
2. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup.
Giannantoni A; Porena M; Costantini E; Zucchi A; Mearini L; Mearini E
J Urol; 2008 Mar; 179(3):1031-4. PubMed ID: 18206941
[TBL] [Abstract][Full Text] [Related]
3. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
Kuo HC; Chancellor MB
BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin a has antinociceptive effects in treating interstitial cystitis.
Smith CP; Radziszewski P; Borkowski A; Somogyi GT; Boone TB; Chancellor MB
Urology; 2004 Nov; 64(5):871-5; discussion 875. PubMed ID: 15533466
[TBL] [Abstract][Full Text] [Related]
6. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis.
Liu HT; Kuo HC
Urology; 2007 Sep; 70(3):463-8. PubMed ID: 17905097
[TBL] [Abstract][Full Text] [Related]
7. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of botulinum toxin for interstitial cystitis/painful bladder syndrome.
Gottsch HP; Miller JL; Yang CC; Berger RE
Neurourol Urodyn; 2011 Jan; 30(1):93-6. PubMed ID: 20589903
[TBL] [Abstract][Full Text] [Related]
9. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.
Giannantoni A; Di Stasi SM; Stephen RL; Bini V; Costantini E; Porena M
J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783
[TBL] [Abstract][Full Text] [Related]
10. Intravesical botulinum type A toxin injection in patients with overactive bladder: Trigone versus trigone-sparing injection.
Lucioni A; Rapp DE; Gong EM; Fedunok P; Bales GT
Can J Urol; 2006 Oct; 13(5):3291-5. PubMed ID: 17076955
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J
J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis.
Schulte-Baukloh H; Schobert J; Stolze T; Stürzebecher B; Weiss C; Knispel HH
Neurourol Urodyn; 2006; 25(2):110-5. PubMed ID: 16470519
[TBL] [Abstract][Full Text] [Related]
13. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
Sahai A; Sangster P; Kalsi V; Khan MS; Fowler CJ; Dasgupta P
BJU Int; 2009 Mar; 103(5):630-4. PubMed ID: 18990156
[TBL] [Abstract][Full Text] [Related]
14. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
[TBL] [Abstract][Full Text] [Related]
15. Bladder botulinum toxin A injection can benefit patients with radiation and chemical cystitis.
Chuang YC; Kim DK; Chiang PH; Chancellor MB
BJU Int; 2008 Sep; 102(6):704-6. PubMed ID: 18485037
[TBL] [Abstract][Full Text] [Related]
16. Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity.
Sahai A; Dowson C; Khan MS; Dasgupta P;
Urology; 2010 Mar; 75(3):552-8. PubMed ID: 20035984
[TBL] [Abstract][Full Text] [Related]
17. Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population.
White WM; Pickens RB; Doggweiler R; Klein FA
J Urol; 2008 Dec; 180(6):2522-6. PubMed ID: 18930481
[TBL] [Abstract][Full Text] [Related]
18. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
19. Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre.
Del Popolo G; Filocamo MT; Li Marzi V; Macchiarella A; Cecconi F; Lombardi G; Nicita G
Eur Urol; 2008 May; 53(5):1013-19. PubMed ID: 17950989
[TBL] [Abstract][Full Text] [Related]
20. Concomitant repeated intravesical injections of botulinum toxin-type A and laparoscopic antegrade continence enema; a new solution for an old problem.
Kajbafzadeh A; Mahboubi AH; Payabvash S
BJU Int; 2009 May; 103(9):1248-54. PubMed ID: 19154454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
